NUAK2 mRNA levels in ovarian cancer are not related to a lower survival rate (Table 2) (Supplementary Figure S2A), whereas high NUAK2 expression in glioma patient samples decreases the survival rate from 13% to 6% (Supplementary Figure S2B), indicating poor prognosis. The gene discussed is NUAK2; the disease is central nervous system cancer.